HEATHER TRAN: Open Payments
NPI 1043734098 · SHERMAN OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,997 in 75 payments from 19 companies in 2025. Trend: 2023 $1,575 · 2024 $1,960 · 2025 $1,997
Food & beverage: $1,997
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $237 |
| Incyte Corporation | 9 | $229 |
| UCB, Inc. | 5 | $190 |
| Regeneron Healthcare Solutions, Inc. | 7 | $189 |
| Amgen Inc. | 10 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $154 |
| Organon LLC | 1 | $140 |
| ABBVIE INC. | 6 | $131 |
| Arcutis Biotherapeutics, Inc. | 6 | $116 |
| Janssen Biotech, Inc. | 4 | $96 |
Products named: DUPIXENT, OPZELURA, Bimzelx, Otezla, VTAMA, Winlevi, Zoryve, TREMFYA.
Industry payments across CA — which companies pay providers there.
